Objectives : ThepurposeofthisstudywastoevaluatetheeffectsofwaterextractsofEucommiae cortex(EC),Psoraleaesemen(PS),andtheircombinationonreceptoractivatorofnuclearfactor-kappa-Bligand(RANKL)-inducedosteoclastdifferentiation. Methods : WeassayedtheproteinexpressionlevelsofnuclearfactorofactivatedT-cells,cytoplasmic1(NFATc1),c-Fos,mitogen-activatedproteinkinases(MAPKs),andβ-actinincell lysatesusingwesternblotting.Similarly,mRNAexpressionlevelsofNFATc1,c-Fos,tartrateresistantacidphosphate(TRAP),andglyceraldehyde-3-phosphatedehydrogenase,spermatogeni(GAPDHS)frombonemarrowmacrophages(BMMs)wereanalyzedusingreverse transcription-polymerasechainreaction(RT-PCR).Furthermore,wedeterminedtheanti-osteoporoticeffectsofthewaterextractsofEC,PS,andtheircombinationinalipopolysaccharide (LPS)-inducedbone-lossmousemodel. Results : Theinvitro datarevealedshowedthatthecombinationofECandPSextractshowed amoreremarkableinhibitionofosteoclastdifferentiationthaneachherbdidalone.Thecombinationdownregulatedtheinductionofc-Fos,NFATc1,andTRAPbysuppressingthephosphorylation of p38 and c-Jun N-terminal kinases (JNKs) and inhibiting nuclear factor kappa-light-chain-enhancerofactivatedBcells(NF-κB).Lastly,theinvivo datashowed thatPSreducedtheLPS-inducedboneerosion. Conclusion : TheresultofthisstudysuggeststhatECandPScouldbepotentialtherapeutic agentsforbonelossdiseasessuchasosteoporosis.
I. Introduction
Bone undergoes a continuous remodeling process of regeneration and degradation. Osteoblasts are involved in bone-forming while osteoclasts are associated with the bone resorption, and an imbalance between these two cell types can lead to the development of bone-related disorders such as osteoporosis 1) . Medications available for osteoporosis in the modern field of medicine include bone resorption inhibitors and bone-forming agents.
Most clinical treatments for osteoporosis involve the use of bone resorption inhibitors that have common side effects including gastrointestinal disturbance mediated by cells in the T-cell lineage and monocytes, 3-day flu-like symptoms 2) , increased bone mass during the early treatment period, jaw bone necrosis with long-term treatment, atypical subtrochanteric fracture, and delayed fracture recovery 3) . These side effects have prompted research on alternative osteoporosis medications derived from natural substances, such as herbal medicines that have few side effects. Furthermore, a previous study has reported that various kinds of herbal medicines can increase the bone mass of the spinal column more significantly than existing medications for osteoporosis 4) . Although there has been no direct report on osteoporosis in the oriental medicine literature, osteoporosis appears to fall under the category of Golwi (骨萎), Golgeuk (骨極), Golbi (骨痺), and Golgo (骨枯) based on its clinical symptoms and patterns 5) .
In addition, EC and PS have function of Bosin (補 腎) according to theories of physiology in oriental medicine, Sinjugol(腎主骨). Thus, in this study, we postulated that EC and PS would have therapeutic effects on osteoporosis 6) .
Previous studies investigating the therapeutic effects of EC extracts on osteoporosis using scientific methods [7] [8] [9] [10] [11] have only used ovariectomized white (albino) mice. Furthermore, a study reported that EC extracts inhibit the expression of nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) by inhibiting the activation of p38, c-Jun N-terminal kinases (JNKs), extracellular signal-regulated kinases (ERKs), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) 12) . However, the experiment conducted in that study used relatively high intracellular extract concentrations of 50-300 μ g/mL 12) .
A previous study, which reported the therapeutic effects of PS extracts in osteoporosis 13) , only used a white mouse model of osteoporosis induced by estrogen deprivation via ovariectomy. Furthermore, the therapeutic effects of the PC extracts were assessed in vivo by assaying related biochemical markers including serum and urine components as well as and bone density 13) . Natural substances and their derivatives with inhibitory cellular effects on different stages of osteoclast differentiation have been investigated including deer antler 14) and Taxilli ramulus extracts [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . There has not been any research on the cellular inhibitory effects of EC and PS extracts on osteoclast differentiation, inflammatory bone loss, or their mechanisms of action and combined effects. Therefore, the present study was aimed at investigating the inhibitory effects of single or combined administration of EC and PS extracts on osteoclast differentiation in a white mouse model of experimentally induced bone loss.
II. Materials and Methods

1.Materials
The receptor activator of nuclear factor-kappa-B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) used in our research were purchased from Peprotech (London, UK). The 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay kit was purchased from Roche (Indianapolis, IN, USA).
Phosphorylated-JNK (p-JNK), JNK, p-ERK, ERK, p-p38, p38, and inhibitor of NF-κB (I-κB) antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). c-Fos, NFATc1, and actin antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
2.Methods
1)Preparation of EC and PS extracts
The EC and PS material used in this study were from Yeongchun of Gyeongbuk Province and China, respectively, and were purchased from Omniherb Company. The EC and PS samples were evenly cut into pieces, macerated for 30 min, and boiled in a heating mantle for 2 h. Freeze-dried samples of the concentrates were used in our experiments, and their yields are shown in Table 1 .
Purified water (1 L) was added to 100 g of each herb and heated in a Glas-Col (Terre Haute, IN, USA) heating mantle for 2 h for the extraction. The obtained extracts were filtered, concentrated using a rotary vacuum evaporator, freeze-dried, and then powdered for use in the experiments. The extract combination was prepared by mixing the EC and PS extracts in a 1:1 ratio, followed by further extraction and processing using the procedure described above.
2)Osteoclast culture and differentiation inhibition
Bone marrow cells were obtained by euthanizing 
3)Toxicity test
BMMs were seeded into a 96-well plate at 1 × 10 4 cells/well and cultured with M-CSF (30 ng/mL), followed by the extracts at different concentrations for 3 days. Then, 50 μ L XTT was added to each well, and after a 4-h incubation, the optical density was measured at 450 nm using an enzyme-linked immunosorbent assay (ELISA) plate reader (Molecular Devices, CA, USA).
4)Western blot analysis
The cultured cells were washed 2-3 times with 
5)Reverse transcription-polymerase chain reaction (RT-PCR)analysis
Intracellular RNA was separated using 1 mL isol-RNA lysis reagent (5PRIME) according to the manufacturer' s instructions. Briefly, 0.5 pg-1 μ g of the separated RNA was used to synthesize cDNA using the ReverTra Ace ® quantitative polymerase chain reaction (qPCR) reverse transcription (RT) kit (Toyobo, Japan). The synthesized cDNA was amplified using PCR with the primers listed in Table 2 . Then, the amplified DNA was electrophoresed using a 1% agarose gel, stained with ethidium bromide (EtBr), and subsequently visualized under ultraviolet (UV) light.
6)Animal experiment
To 
7)Statistical analysis
The statistical analysis was performed thrice or more for each experimental group, and the results are presented as the means ± standard deviation 
III. Results
1)Inhibitory effects of EC and PS water extracts in combination on RANKLinduced osteoclast differentiation
The (Fig. 1A) . The number of multinucleated osteoclasts after staining with TRAP was counted, and the results revealed that differentiation into multinucleated osteoclasts was significantly inhibited by the EC and PS extracts (Fig. 1B ).
In the subsequent experiments, the EC and PS extracts were used at a concentration of 10 μ g/mL.
2)Effects of EC and PS extracts alone on RANKL-induced osteoclast differentiation
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Fig. 2.Eucommiaecortex(EC)andPsoraleaesemen(PS)inhibitosteoclastdifferentiation
Bone marrow macrophages (BMMs) were cultured for 4 days with macrophage colony-stimulating factor (M-CSF, 30 ng/mL) and receptor activator of nuclear factor-kappa-B ligand (RANKL, 100 ng/mL) in the presence or absence of EC or PS.
(A) After 4 days, cells were fixed in 3.7% formalin, permeabilized in 0.1% Triton x-100, and stained for tartrate-resistant acid phosphate (TRAP).
(B) TRAP-positive cells were counted as osteoclasts. *statistically different from control (***p < 0.001).
A B thermore, the differentiation of BMMs into mature, multinucleated osteoclasts was also inhibited.
However, this inhibition was not significant compared with that observed in the combination group.
The PS extract inhibited osteoclast differentiation;
however, the cells treated at a concentration of 10 μ g/mL exhibited cytotoxicity (Fig. 2 ). we set the concentration of the EC and PS extracts at 5 μ g/mL and that of the extract combination at 10 μ g/mL. At this concentration, the extract combination exhibited synergistic effects over those of the EC and PS extracts while cytotoxicity was not observed (Fig. 3) . (Fig. 4) .
2.Cytotoxicity of EC and PS extracts
2)Effects of EC and PS alone on RANKL-induced protein expression
The Bone marrow macrophages (BMMs) were pretreated with or without EC and PS water extracts (10 μ g/mL) for 1 h and then stimulated with RANKL (100 ng/mL) for indicated times. Cell lysates were analyzed using western blotting with antibodies for c-Fos, NFATc1, and β-actin.
pendent manner, and that of c-Fos was increased at 12 and 24 h. However, the expression of c-Fos and NFATc1 proteins was inhibited in the combination treatment group (Fig. 6) .
2)Effects of EC and PS extracts alone on RANKL-induced expression of CFos and NFATc1proteins
The expression of NFATc1 increased in a time- 
5.Effects on signaling pathways of osteoclast differentiation 1)Effects of the combination of EC and PS extracts on signaling pathways of RANKL-induced osteoclast differentiation
We investigated the effects of EC and PS extracts alone and in combination on major signaling pathways induced by RANKL to identify the mechanisms of osteoclast differentiation inhibition.
BMMs were pretreated with the EC and PS extracts alone or in combination, followed by RANKL at 0, 5, 15, and 30 min, and MAPK phosphorylation was assessed. While phosphorylation of AKT, p38, and JNK was increased in the EC and PS groups, phosphorylation of p38 and JNK was simultaneously inhibited in the combination group. The proteolysis of I-κB was also inhibited by RANKL (Fig. 8) .
2)Effects of EC and PS extracts alone on signaling pathways of RANKL-induced osteoclast differentiation
BMMs were pretreated with EC and PS extracts, followed by RANKL at 0, 5, 15, and 30 min, and then MAPK phosphorylation was assessed. The phosphorylation of AKT and p38 was inhibited in the EC group, and that of p38 and JNK was inhibited in the PS group (Fig. 9 ).
6.Effects on LPS-induced inflammatory bone loss
A mouse model of inflammatory bone loss was used to investigate the in vivo effects of EC and PS
Fig. 7.Eucommiaecortex(EC)andPsoraleaesemen(PS)suppressesreceptoractivatorofnuclearfactor-kappaBligand(RANKL)-inducedc-FosandnuclearfactorofactivatedT-cells,cytoplasmic1(NFATc1)expression
Bone marrow macrophages (BMMs) were pretreated with or without EC and PS (5 μ g/mL) for 1 h and then stimulated with RANKL (100 ng/mL) for indicated times. Cell lysates were analyzed using western blotting with antibodies for c-Fos, NFATc1, and β-actin.
InhibitoryEffectsofWaterExtractsofEucommiaeCortexandPsoraleaeSemenAloneandinCombinationonOsteoclast DifferentiationandBone
Fig. 8.Eucommiaecortex(EC)plusPsoraleaesemen(PS)waterextractsinhibitreceptoractivatorofnuclearfactor-kappa-BligandRANKLsignalingpathways
Bone marrow macrophages (BMMs) were pretreated with or without EC and PS water extracts (10 μg/mL) and further stimulated with RANKL(100 ng/mL) for indicated times. Cells were lysed, proteins were resolved using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and subjected to western blot analysis. p-JNK, phosphorylated-c-Jun N-terminal kinase; inhibitor of nuclear factor kappa-light-chain-enhancer of activated B cells, I-κB.
Fig. 9.Eucommiaecortex(EC)andPsoraleaesemen(PS)inhibitreceptoractivatorofnuclearfactor-kappa-BligandRANKLsignalingpathways
Bone marrow macrophages (BMMs) were pretreated with or without EC and PS (5 μ g/mL) and further stimulated with RANKL (100 ng/mL) for indicated times. Cells were lysed, proteins were resolved using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and subjected to western blot analysis. p-JNK, phosphorylated-c-Jun N-terminal kinase; inhibitor of nuclear factor kappa-light-chain-enhancer of activated B cells, I-κB.
extracts alone and in combination. LPS (5 μ g/g)
was intraperitoneally injected into the mice once every 3 days, and then each extract was orally administered once daily at various concentrations.
The extent of LPS-induced bone loss was assessed based on 3D images of the femur specimens obtained using the Skyscan BE/skyscan 1172 ( Table   3 ). (Fig. 10) .
IV. Discussion
Osteoporosis is a systemic musculoskeletal disorder characterized by reduced bone mass and microstructure abnormalities and is a major geriatric disease that causes the bones to weaken and become brittle 27) . The aging population has led to an increase in the number of patients with osteoporosis. 28 Bone diseases such as osteoporosis are be- EC is the dried bark of Eucommia ulmoides OLIV.), which belongs to the Eucommiaceae family.
The bark is peeled off the trees in April and May, cut, stacked, and dried until the inner side turns purplish brown. EC is mild, non-toxic (溫無毒), and has a sweet and slightly spicy taste (甘微辛). It effects on (歸經) the kidney and liver meridian (肝腎 經) and strengthens muscle and bone (强筋骨) and, therefore is used to treat numbness and weakness of feet and knees (足膝痿弱) and other diseases 6) . It is combined with Psoraleae semen to treat chills and pain in the waist and knees (腰膝酸痛) and musculoskeletal weakness (筋 骨 無 力 ) caused by liver and kidney yang deficiencies (肝腎不足) 31) . Psoraleae fructus is the dried ripe fruit of Psoralea corylifolia L., which is an annual herb that ) or 1× phosphate-buffered saline (PBS) daily for 10 days. LPS (5 µg/g body weight) or 1× PBS was administered intraperitoneally on day 4 and 7, and the femurs were harvested on day 10 after EC, PS, and EC + PS extract treatments. Radiographs were captured using Skyscan. (B) Bone volume/tissue volume (BV/TV), trabecular thickness, separation, and number were analyzed using histomorphometric results. *Statistically different from LPS group. (*p < 0.05).
A B
to kidney-Gi with warm medicine (溫 腎 助 陽 ).
Therefore, it is used to treat cold feeling and pain in the waist and knees (腰膝冷痛) 6) . It is combined with EC to treat kidney yang deficiency and back pain 31) . NF-κB is a transcription factor involved in differentiation, survival, and activation of various cells and is known to be involved in the expression of NFATc1 in osteoclasts 37) . I-κB binds NF-κB in the cytoplasm to prevent it from traveling to the nucleus while RANKL destroys I-κB to enable NF-κB to translocate the nucleus. Continuous expression of I-κB inhibits NF-κB activity and ultimately inhibits differentiation into osteoclasts 38) . We investigated the effects of EC and PS extracts and their combination on the activation of NF-κB. The level of I-κB was reduced at 5 and 10 min as I-κB was degraded by RANKL. However, in the combination group, the level of I-κB was unchanged over time. Therefore, the inhibition of NFATc1 expression by the combination of the EC and PS extracts may be associated with inhibition of NF-κB activation.
Considering
A study using an LPS-induced rat model of inflammation, which is commonly used in research on bone loss and destruction in chronic inflammatory environments, reported that osteoclast differentiation is promoted by LPS 39) . EC has been reported to increase bone density and bone strength in white rat models of induced osteoporosis when coadministered with PS and treadmill exercise and, therefore, could be effective in the treatment of osteoporosis 41) . EC administered to ovariectomized white rats has been observed to increase the trabecular bone volume 10) .
PS has been observed to reduce the serum level of osteocalcin and increase the level of phosphorus and calcium in bones in ovariectomized white rats and, thus, has been reported to be effective in the prevention and treatment of osteoporosis 42) . 
V. Conclusion
We investigated whether single extracts of EC and PS and their combination had inhibitory effects on RANKL-induced osteoclast differentiation as well as bone resorption.
1. Based on the TRAP assay results, RANKL-induced osteoclast differentiation was more significantly inhibited by the combination of EC and PS extracts than by each of the extracts alone.
2. The EC and PS extracts at a concentration of 5 μ g/mL showed no cytotoxicity and, therefore, were used in the experiment. The extract combination was prepared by mixing the EC and PS extracts in a 1:1 ratio and was used at a concentration of 10 μ g/mL since no cytotoxicity was observed at this concentration. In the in vivo experiment, the EC and PS extract combination had no effects on recovery from LPSinduced bone loss and the BV/TV was increased in the PS-and LPS-treated group, indicating a significant recovery of bone mass compared to the recovery in the group treated with LPS only.
In conclusion, the EC and PS extracts inhibited osteoclast differentiation through different routes.
The inhibition of osteoclast differentiation was enhanced when the extracts were coadministered.
Only the single extract of PS was effective against bone loss caused by inflammation.
